Manufacturing & Supply Chain

Abbott turns sod on new Irish manufacturing site

 Breaking News

Abbott turns sod on new Irish manufacturing site

Abbott turns sod on new Irish manufacturing site
April 17
09:40 2023
Spread the love

Abbott, a global leader in healthcare, has commenced the construction of its new manufacturing facility in Kilkenny, which will be a global centre of excellence for the company’s life-changing FreeStyle Libre 3 continuous glucose monitoring portfolio. The 30,000 sq m facility will employ in the region of 300 people during construction and more than 800 people by the time manufacturing starts in 2024.

Recruitment for permanent positions is underway and almost 50 employees have already started working in Kilkenny. The new roles will be in engineering, quality control, medical device manufacturing and other science-based areas. The company is actively recruiting and anyone wishing to learn more about the opportunities available or register their interest in working with Abbott, can visit

Speaking at a sod turning event, Simon Harris TD, Minister for Justice and Minister of Further and Higher Education, Research, Innovation and Science, said: “With a footprint in all four provinces, Abbott has played a leading role over the past 77 years in establishing Ireland as a location for the global medtech sector. This new investment in Kilkenny will add to the high value STEM jobs already created in the South-East region by Abbott at its vascular manufacturing facility in Clonmel. This is an important investment for Ireland, and I am delighted to congratulate Abbott on this new diabetes care manufacturing facility in Kilkenny.”

Jared Watkin, Senior Vice President of Abbott’s Diabetes Care Business, said: “Abbott’s FreeStyle Libre is the number one sensor-based glucose monitoring system in the world, having changed the lives of 4.5 million people across more than 60 countries by providing breakthrough technology that is accessible and affordable. This new facility, together with our diabetes care facility in Donegal, will help us meet the growing demand and bring new highly skilled jobs to the community.”

Abbott announced in August last year that it is investing €440 million in significantly expanding manufacturing operations for its Diabetes Care business in Ireland. In addition to the new manufacturing facility in Kilkenny, the company announced the expansion of operations at its existing facility in Donegal.

The building of Abbott’s new facility in Kilkenny is supported by the Irish Government through IDA Ireland. Mary Buckley, Interim CEO of IDA Ireland, said: “This investment, announced last year, is a further testament to the deep roots the company has in Ireland. IDA Ireland’s strategy to win investments and jobs in regional locations includes encouraging and supporting established companies to develop additional regional sites and this is a prime example. This new manufacturing facility will deliver a substantial boost to the economy of the South East.”

Abbott was one of the first multinational companies to establish in Ireland and is the only one with operations in all four provinces. This new investment will bring Abbott’s total employment in the country to approximately 6,000 people across 10 sites, including seven manufacturing operations.

Warning: count(): Parameter must be an array or an object that implements Countable in /home/manufacturingsup/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5

About Author



Related Articles



New Subscriber

    Subscribe Here


    National Manufacturing Conference & Exhibition 2020

    NIBRT Springboard Success Stories